Results were recently published in a study in the Journal of Clinical Microbiology that show limitations of currently available diagnostic tests for early-stage Lyme disease, and highlight the need for more research toward improved diagnostics and treatments.
Joining me today to discuss the study and the findings is Liz Horn, PhD. Dr Horn is the Principal Investigator with the Lyme Disease Biobank.
The Lyme Disease Biobank – Characterization of 550 Patient and Control Samples from the East Coast and Upper Midwest of the United States
Lyme Disease Biobank
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Android | Stitcher |
Hand Soaps & Sanitizers at Dollar Tree!
Lyme disease in the US: The Quest Diagnostics Health Trends report
One Health with Cheryl Stroud, DVM, PhD
Lyme disease: The major players, the disagreements and the IDSA draft guidelines
Lyme testing with Monica Embers, PhD
Lyme disease: New study confirms dogs are sentinels to assess human risk
Lyme ‘persister’ bacteria and a three-antibiotic cocktail: A study
Lyme disease, ticks and the ecology with Richard Ostfeld, PhD
Asian longhorned ticks with Maria Diuk-Wasser, PhD
Chikungunya and Lyme vaccine candidates with Valneva CEO Thomas Lingelbach
Lyme disease, the Federal Tick-borne Disease Working Group and an IDSA letter with Timothy Sellati, PhD